Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysozyme-like protein 4 (LYZL4) is a member of the c-type lysozyme family, sharing the characteristic structural features such as a signal peptide and conserved cysteine residues necessary for proper folding and stability[3]. Unlike classical lysozymes, LYZL4 does not retain critical active site residues for muramidase (enzymatic) activity, suggesting it is enzymatically inactive against bacterial peptidoglycans[3]. LYZL4 is specifically expressed in the testicular germinal epithelium and localizes to the tail of maturing spermatozoa. This localization pattern indicates a specialized role in sperm function, possibly in motility or maturation, but not in antibacterial host defense or conventional enzyme activity[3]. It is not broadly considered a therapeutic target or a disease-associated protein at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysozyme-like protein 4 (LYZL4).